Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sildosin as a Male Contraceptive Non Hormonal
Sponsor: Benha University
Summary
In all, 200 healthy, sexually active, fertile male candidates will be assigned 100 in silodosin group and 100 in placebo group. Males using other contraceptive methods will be excluded. Follow up data of total spermatozoa per ejaculate, semen volume and Post-ejaculation urinalysis after 2, 6 and 12 weeks of the studied groups will be recorded. The various side effects reported in the study groups after 12 weeks from the start of the study will be recorded.
Official title: A Prospective Study to Evaluate the Efficacy of Silodosin 8 mg as an on-Demand, Reversible, Nonhormonal Oral Contraceptive for Males:
Key Details
Gender
MALE
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-09
Completion Date
2025-12
Last Updated
2025-09-26
Healthy Volunteers
No
Conditions
Interventions
Oral intake of sildosin
Oral intake of sildosin in male non hormonal contraception
Oral intake of placebo
Intake of placebo to compare effecacy of other group